Bli medlem
Bli medlem

Du är här


Phase Holographic: Cell laboratory at Japanese university orders 3rd HoloMonitor

One of the cell laboratories at Kyushu University in Japan has ordered
two HoloMonitor® instruments to complement the instrument previously
purchased by the laboratory. The university is one of the seven
imperial universities which today form Japan's prestigious national
universities. An additional four HoloMonitor M4.5 instruments have
recently been ordered by customers in the UK, Israel, Australia and
Singapore. The total retail price of the ordered units amounts to
€144 000.

"The follow-up order from Kyushu University once again confirms the
scientific value of our HoloMonitor-technology. Furthermore, the
order indicates that cell laboratories will require several
instruments to accommodate the expanding research needs created by
HoloMonitor technology. The laboratory at Kyushu University will
become the 9th cell laboratory with several HoloMonitor instruments
in operation. Independent market reports estimate the number of cell
laboratories in the world to approximately 120 000", said CEO Peter


· The Market for Cell-Based Assays -

For additional information, please contact:

Peter Egelberg, CEO

Tel: +46 703 19 42 74



Phase Holographic Imaging (PHI) leads the ground-breaking development
of time-lapse cytometry instrumentation and software. With the first
instrument introduced in 2011, the company today offers a range of
products for long-term quantitative analysis of living cell dynamics
that circumvent the drawbacks of traditional methods requiring toxic
stains. Headquartered in Lund, Sweden, PHI trades through a network
of international distributors. Committed to promoting the science and
practice of time-lapse cytometry, PHI is actively expanding its
customer base and scientific collaborations in cancer research,
inflammatory and autoimmune diseases, stem cell biology, gene
therapy, regenerative medicine and toxicological studies.


Författare ATORG

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.